...
首页> 外文期刊>Journal of Colloid and Interface Science >Polyelectrolyte complex templated synthesis of monodisperse, sub-100 nm porous silica nanoparticles for cancer targeted and stimuli-responsive drug delivery
【24h】

Polyelectrolyte complex templated synthesis of monodisperse, sub-100 nm porous silica nanoparticles for cancer targeted and stimuli-responsive drug delivery

机译:聚电解质复杂模板合成单分散,亚100nm多孔二氧化硅纳米粒子用于癌症靶向和刺激反应药物递送

获取原文
获取原文并翻译 | 示例
           

摘要

Porous silica nanoparticles (PSiNPs) have long attracted interest in drug delivery research. However, conventional synthesis methods for sub-100 nm, functionalised PSiNPs typically give poor monodispersity, reproducibility, or involve complex synthetic protocols. We report a facile, reproducible, and cost-effective one-pot method for the synthesis of cancer targeting and pH responsive PSiNPs in this size range, without the need for post-synthetic modification. This was achieved by using monodisperse L-arginine (Arg)/ poly(acrylic acid) (PAA) polyelectrolyte complexes (PECs) as soft templates for silane hydrolysis and condensation. Highly uniform PSiNPs with tunable size control between 42 and 178 nm and disordered pore structure (1.1-2.7 nm) were obtained. Both PAA and Arg were retained within the PSiNPs, which enabled a high doxorubicin hydrochloride (Dox) loading capacity (22% w/w) and a 4-fold increase in drug release under weakly acidic pH compared to physiological pH. The surface presentation of Arg conferred significantly higher intracellular accumulation of Arg/PAA-PSiNPs in patient-derived glioblastoma cells compared to non-tumorigenic neural progenitor cells, which effectively translated to lower IC50 values for Dox-loaded Arg/PAA-PSiNPs than non-functionalised PSiNPs. This work brings forward new insights for the development of monodisperse PSiNPs with highly desirable built-in functionalities for biomedical applications. (C) 2020 The Authors. Published by Elsevier Inc.
机译:多孔二氧化硅纳米颗粒(PSiNPs)长期以来一直吸引着药物递送研究的兴趣。然而,用于小于100 nm的官能化PSINP的传统合成方法通常具有较差的单分散性、再现性或涉及复杂的合成方案。我们报告了一种简便、重复性好、成本效益高的一锅法,用于合成这种大小范围内的肿瘤靶向性和pH响应性PSINP,无需进行合成后修饰。这是通过使用单分散的L-精氨酸(Arg)/聚(丙烯酸)(PAA)聚电解质复合物(PEC)作为硅烷水解和缩合的软模板实现的。获得了高度均匀的PSiNPs,尺寸可调,控制在42-178nm之间,孔结构无序(1.1-2.7nm)。PAA和Arg均保留在PSINP中,这使得盐酸阿霉素(Dox)的载药量高(22%w/w),在弱酸性pH条件下,药物释放量比生理pH条件下增加4倍。与非致瘤性神经祖细胞相比,患者来源的胶质母细胞瘤细胞中Arg的表面呈现使Arg/PAA psinp的细胞内积累显著增加,与非功能化PSINP相比,Dox负载的Arg/PAA PSINP有效地降低了IC50值。这项工作为单分散PSiNPs的开发提供了新的见解,这些单分散PSiNPs具有非常理想的生物医学应用内置功能。(C) 2020年,作者。爱思唯尔公司出版。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号